212-500-4603
ccm.team@scientiae.com
Account
Login
Username
(Required)
Password
(Required)
Remember Me
Register
Forgot Password?
Home
Treatment Team
FAQs
Past Events
Virtual Workshop
In-Person Workshop
On Demand Workshop
Contact Us
CCM Workshop
Saturday, December 11, 2021
Houston, Texas
30-Day Post-Meeting Survey
Name
*
First
Last
Email
*
(Please ensure that this is the email used for registration.)
The knowledge or skills gained from the workshop have been applied to my clinical practice.
*
Yes
No
Not yet
As a result of participating in this workshop, please rate the degree to which you are now able to…
*
Excellent
Good
Satisfactory
Fair
Poor
N/A
Recognize the importance, benefits, challenges, and practical concerns regarding the interdisciplinary team approach for management of patients with spasticity, in order to develop individualized treatment plans
Interpret the clinical evidence, guidelines, and recommendations on the use of neurotoxins and adjunctive rehabilitation interventions (physical therapy [PT]/occupational therapy [OT]/speech-language pathology [SLP]), both alone and in combination, in order to establish appropriate treatment strategies for these patients
Assess neuromuscular pathology and individual patient functional goals, in order to identify appropriate muscles, determine dosing, maximize therapeutic benefit, and minimize complications
Evaluate methods of guidance and localization (ie, EMG, E-Stim, ultrasound), in order to incorporate best practices for proper placement of neurotoxin
Apply optimal guidance and localization techniques, especially ultrasound technology, in order to improve efficacy in injecting BoNT for treatment of spasticity
Integrate home exercise programs into spasticity management post-BoNT, in order to optimize patient rehabilitation outcomes
Facilitate interaction and improve communication among members of the interdisciplinary treatment team, in order to encourage appropriate referrals for both neurotoxin injection and adjunctive therapy that may optimize patient outcomes
Please review the case below and answer the questions that follow.
(Please be sure to complete this item before continuing with the survey)
60-year-old female who suffered a right cerebral infarct 4 years ago
Her exam is notable for the following:
Spastic left hemiplegia
Left elbow flexion
Left clenched fist
Left foot inversion with gait
She was recently injected with neurotoxin to her left elbow flexors, finger flexors, foot inverters and toe flexors, and referred to you for post-injection evaluation and therapy.
Please rank the importance of the following assessments in determining your treatment plan for this patient (Top=most important, Bottom=least important)
Range of motion assessment, both active and passive
Modified Ashworth Scale scores
Instrumented gait analysis
Patient’s stated symptoms and goals
Other
Please specify 'Other' above
Describe the muscle stretching and strengthening techniques that would likely benefit this patient.
*
Differentiate those techniques that you would perform in the office from those you would have the patient perform at home.
*
How often do you receive referrals for post-injection therapy in this type of patient?
*
Never
Occasionally
Frequently
Very Frequently
How often do you refer patients with spasticity and related speech, language, or swallowing disorders to physicians for consideration of neurotoxin injections?
*
Never
Occasionally
Frequently
Very Frequently
How do you most efficiently manage communications with other members of the patient’s treatment team?
*
As a result of this workshop, I have implemented changes in my practice in the following areas:
*
Overall Evaluation
Yes
No
Clinician-Patient Communication
Documentation (appropriate)
Patient Education
Clinician-Clinician Communication
Quality Improvement
Patient Safety
Treatment Approach
Did you change your practice by implementing the workshop’s recommended management strategies, and if so, how quickly after?
*
Yes, within 11-14 days
Yes, within 15-31 days
No, not yet
N/A
Utilized more refined screening criteria to identify patients for neurotoxin treatment
Referred patients where appropriate for neurotoxin treatment
Recommended or prescribed PT/OT/SLP where indicated for patients receiving neurotoxin treatment
Used routine outcome measurements (eg, Modified Ashworth Scale) more often or more consistently
Established or strengthened case documentation shared by treatment team members
Formed or expanded a treatment team of interdisciplinary members for case management
Shared workshop course materials with clinicians who did not participate in this workshop
More often or more consistently discussed with patients the importance of home exercise therapy as an adjunct to their clinical care
I have implemented the following specific change in my practice.
Please describe at least one clinical outcome in a specific patient case that you achieved or improved based on the skills and knowledge you developed in this workshop (please include HIPAA-/patient confidentiality–compliant patient descriptions):
Are there any specific lectures/topics that you would like covered at future workshops?
What is your specialty focus?
*
Neurology
Physiatry
Occupational Therapy
Physical Therapy
Speech-Language Pathology
Other
Please specify your specialty focus
*
Type of practice:
*
Hospital Setting
Long-term Care/Skilled Nursing Facility
Early Intervention Service
Private Practice/office based
School Health Program
Academic Institution
Outpatient Clinic
Home Health Care
Other
Please specify your type of practice
*
